Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-22-011337
Filing Date
2022-03-17
Accepted
2022-03-17 07:58:16
Documents
1
Period of Report
2022-03-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4429
  Complete submission text file 0000899243-22-011337.txt   5817
Mailing Address DYAX CORP. 55 NETWORK DRIVE BURLINGTON MA 01803
Business Address
ADELMAN BURT A (Reporting) CIK: 0001226283 (see all company filings)

State of Incorp.: MA | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-40489 | Film No.: 22746797

Mailing Address 500 TECHNOLOGY SQUARE CAMBRIDGE MA 02139
Business Address 500 TECHNOLOGY SQUARE CAMBRIDGE MA 02139 (978) 501-3026
Verve Therapeutics, Inc. (Issuer) CIK: 0001840574 (see all company filings)

EIN.: 824800132 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations